We are live on ! Find out more

19 hedge funds and large institutions have $5.96M invested in Myomo in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

491% more capital invested

Capital invested by funds: $1.01M → $5.96M (+$4.95M)

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

27% more funds holding

Funds holding: 1519 (+4)

13.12% more ownership

Funds ownership: 6.14%19.27% (+13%)

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
4
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MYO Hedge Fund Activity: Q4 2020 in Review

19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q4 2020, worth a combined $5.96M — up 491% from $1.01M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MYO positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Worth Venture Partners, opening a new position worth an estimated $624K. The largest seller was UBS Group, cutting an estimated $2.68K.

  • 19 institutional investors held Myomo (MYO) as of Q4 2020, up from 15 in Q3 2020.
  • Funds reported $5.96M of Myomo stock for Q4 2020, up 491% quarter-over-quarter.
  • 6 funds opened new Myomo positions in Q4 2020 and 1 closed out, a net change of +5 holders.
  • The largest Myomo buyer in Q4 2020 was Worth Venture Partners, an estimated $624K added.
  • The largest Myomo seller in Q4 2020 was UBS Group, an estimated $2.68K sold.

Based on aggregated 13F filings for Q4 2020.